{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T05:34:45Z","timestamp":1739511285303,"version":"3.37.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.msard.2025.106300","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T16:36:52Z","timestamp":1737823012000},"page":"106300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Is there truly no progression in NMOSD and MOGAD?"],"prefix":"10.1016","volume":"94","author":[{"given":"J","family":"Lechner-Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Giovannoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hawkes","family":"CH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeh","family":"EA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106300_bib0018","article-title":"Diffusion tensor imaging changes of the cortico-thalamic-striatal tracts correlate with fatigue and disability in people with relapsing-remitting MS","volume":"170","author":"Alshehri","year":"2023","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"10.1016\/j.msard.2025.106300_bib0012","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jon.13175","article-title":"A longitudinal analysis of brain volume changes in myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"34","author":"Amin","year":"2024","journal-title":"J. Neuroimaging"},{"issue":"3","key":"10.1016\/j.msard.2025.106300_bib0001","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.msard.2025.106300_bib0017","doi-asserted-by":"crossref","first-page":"fcac065","DOI":"10.1093\/braincomms\/fcac065","article-title":"Longitudinal tracking of axonal loss using diffusion magnetic resonance imaging in multiple sclerosis","volume":"4","author":"Boonstra","year":"2023","journal-title":"Brain Commun."},{"issue":"6","key":"10.1016\/j.msard.2025.106300_bib0014","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/brain\/awac480","article-title":"MAGNIMS study group. Clinical and MRI measures to identify non-acute MOG-antibody disease in adults","volume":"146","author":"Cortese","year":"2023","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.msard.2025.106300_bib0004","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","article-title":"Secondary progressive Multiple sclerosis: new insights","volume":"97","author":"Cree","year":"2021","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.msard.2025.106300_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurad.2024.101235","article-title":"MRI management of NMOSD and MOGAD: proposals from the French expert Group NOMADMUS","volume":"52","author":"Durand-Dubief","year":"2025","journal-title":"Journal of Neuroradiology"},{"issue":"2","key":"10.1016\/j.msard.2025.106300_bib0002","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(20)30432-4","article-title":"Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care","volume":"20","author":"Fadda","year":"2021","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.msard.2025.106300_bib0015","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106300_bib0011","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41582-024-01005-2","article-title":"The influence of MOGAD on diagnosis of multiple sclerosis using MRI","volume":"20","author":"Geraldes","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2025.106300_bib0006","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/jnnp-2013-306906","article-title":"Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study","volume":"85","author":"Jacobsen","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.msard.2025.106300_bib0013","article-title":"Volumetric brain changes in MOGAD: a cross-sectional and longitudinal comparative analysis","volume":"69","author":"Lotan","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9","key":"10.1016\/j.msard.2025.106300_bib0008","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1177\/1352458517717341","article-title":"Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: an Italian collaborative study","volume":"24","author":"Ruano","year":"2018","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2025.106300_bib0016","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1212\/01.wnl.0000168837.87351.1f","article-title":"Brain atrophy and lesion load in a large population of patients with multiple sclerosis","volume":"65","author":"Tedeschi","year":"2005","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.msard.2025.106300_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103693","article-title":"MOGAD: a comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally","volume":"24","author":"Trewin","year":"2025","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.msard.2025.106300_bib0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1352458512451510","article-title":"Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis","volume":"19","author":"Tutuncu","year":"2013","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.msard.2025.106300_bib0007","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1093\/brain\/awp278","article-title":"Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis","volume":"132","author":"Yeh","year":"2009","journal-title":"Brain"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T02:04:20Z","timestamp":1739498660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":17,"alternative-id":["S2211034825000446"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106300","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there truly no progression in NMOSD and MOGAD?","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106300"}}